期刊文献+

原发性干燥综合征诊治进展 被引量:23

Progress in the diagnosis and treatment of primary sjogren's syndrome
下载PDF
导出
摘要 干燥综合征(Sjogren’s Syndrome,SS)是一种以侵犯唾液腺和泪腺等外分泌腺、具有高度淋巴细胞浸润为特征的系统性自身免疫病。口、眼干燥为常见的症状,常出现皮肤、肺、肝、肾、神经及血管等多系统损害。本病分为原发性(pSS)和继发性两类。本文重点介绍了pSS的发病机制、病理改变、临床表现、实验室检查、诊断标准及治疗最新进展。 Sjogren's syndrome is a chronic autoimmune disorder, characterized by lymphocytic infiltration and malfunction of the exocrine glands, resulting in dry mouth and eyes. The syndrome can present either alone ( primary Sjogren's syndrome ) or secondary to an underlying connective tissue disease ( secondary Sjogren's syndrome ). Systemic impairments, resulting from cutaneous, respiratory, hepatic, renal, neurologic, and vascular involvement, often occur. This article emphatically introduces the pathogenesis, pathologic changes, clinic manifestation, laboratory examination, diagnostic standard, latest treatment progress of primary Sjogren's syndrome.
出处 《实用医院临床杂志》 2007年第3期6-8,共3页 Practical Journal of Clinical Medicine
关键词 干燥综合征 诊断 治疗 原发性 Sjogren's syndrome Diagnosis Treatment
  • 相关文献

参考文献10

  • 1[1]Jacobsson LTH,Axell TE,Hansen BU,et al.Dry eyes and mouth:an epidemiological study in Sweden adult,with special reference to primary Sj gren's syndrome[J].J Autoimmun,1989,2:521.
  • 2[2]Tsubota K,Hirai S,King LS,et al.Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjgren's syndrome[J].Lancet,2001,357(9257):688-689.
  • 3[3]Hulkkonen J,Pertovaara M,Kantonen J,et al.Genetic association between interleukin-10 promoter region polymorphisms and primary sjogren's syndrome[J].Arthritis Rheum,2001,44(1):176-179.
  • 4[4]Witte T,Matthias T,Arnett FC,et al.IgA and IgG autoantibodies against α-Fodrin as markers for SS[J].J Rheumatol,2000,27(11):2617-2620.
  • 5赵岩,董怡.第八届干燥综合征国际专题会议纪要[J].中华内科杂志,2003,42(2):131-132. 被引量:25
  • 6[6]Zhu Z,Stevenson D,Schechter JE,et al.Prophylactic effect of IL-10 gene transfer on induced autoimmune dacryoadenitis[J].Invest Ophthalmol Vis Sci,2004,45(5):1375-1381.
  • 7[7]Koski H,Janin A,Humphreys-Beher MG,et al.Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjogren's syndrome[J].Clin Exp Rheumatol,2001,19(2):131-137.
  • 8[8]Pijpe J,Imhoff GW,Spijkervet FK,et al.Rituximab treatment in patients with primary Sjogren's syndrome:an open-label phase Ⅱ study[J].Arthritis Rheum,2005,52(9):2740-2750.
  • 9[9]Epratuzumab Steinfeld SD,Tant L,Burmester GR,et al.(humanised anti-CD22 antibody) in primary Sjogren's syndrome:an open-label phase Ⅰ/Ⅱ study[J].Arthritis Res Ther,2006,8(4):129.
  • 10[10]Mariette X,Ravaud P,Steinfeld S,et al.Inefficacy of infliximab in primary Sjogren's syndrome:results of the randomized,controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS)[J].Arthritis Rheum,2004,50(4):1270-1276.

共引文献24

同被引文献136

引证文献23

二级引证文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部